Point72 Asset Management, L.P.
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1603466
STAMFORD, CT
Position in RARE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,714,530
-$46,066 QoQ
Shares Held
893,295
+73.1% QoQ
Ownership
0.907%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Derivatives in RARE
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$2,416,680
PutShares
58,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,392,275,927 across 187 Biotechnology names. RARE ranks #35 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in RARE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,714,530 | 893,295 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $18,760,596 | 515,968 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $35,342,842 | 976,052 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $49,763,635 | 1,182,877 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $36,310,813 | 653,660 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,183,683 | 539,749 | Shares | Defined | 2024-09-16 | |
| 2024-06-30 | $2,416,680 | 58,800 | Put | Defined | 2024-09-16 | |
| 2024-03-31 | $2,843,421 | 60,900 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,901,550 | 102,500 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $25,541,870 | 716,462 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,599,437 | 424,874 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $55,613,126 | 1,386,861 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,713,738 | 727,687 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $14,521,948 | 350,687 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,317,904 | 273,515 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,129,252 | 318,497 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $35,811,744 | 425,874 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $30,698,331 | 340,374 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $67,441,055 | 707,300 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $13,617,656 | 119,600 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,570,071 | 119,700 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||